09222017Headline:

Philadelphia, Pennsylvania

HomePennsylvaniaPhiladelphia

Sheller, P.C.

Risperdal Lawsuit Featured on “Full Measure” TV

There is no disputing that medicine has saved countless lives. But, there is also no disputing that prescription drugs are a leading cause of death in our over-prescribed country. Each year, drugs that are properly prescribed in the U.S. cause […]

Sheller, P.C.

Xarelto Sales Continue to Rise Despite Lawsuits

There has been a mounting number of suits being filed against Bayer, the makers of the blood thinner Xarelto, with allegations contending the drug causes severe internal bleeding that leads to hospitalizations, serious injury and even death. But, interestingly, that […]

Sheller, P.C.

Risperdal Gynecomastia Lawsuit – $70 Million Jury Verdict in Philadelphia Court

In an unprecedented jury verdict, Andrew Yount, a Tennessee plaintiff was awarded $70 million in a Risperdal trial. Andrew Yount v. Janssen Pharmaceuticals, the fifth Risperdal case, awarded $70 million in damages for emotional distress and physical disfigurement that was […]

Sheller, P.C.

Risperdal Gynecomastia Lawsuit: “One-Off” Not Indication of Looming Global Settlement

The most recent Risperdal case settled before trial, but that doesn’t mean a global settlement is underway in the mass tort, according to a lawyer handing the litigation. Moffat v. Janssen Pharmaceuticals, settled in May for an undisclosed amount. The […]

Sheller, P.C.

Heartburn Drugs Nexium, Prilosec, Prevacid Linked to Kidney Failure

Popular prescription heartburn medications may cause long-term kidney damage, according to a study published in JAMA Internal Medicine. Nexium, Prevacid and Prilosec, are in a class of drugs called proton pump inhibtors (PPIs) that are used to treat acid reflux […]

Sheller, P.C.

Zofran Lawsuits: New Study Claims Drug Not Linked to Birth Defects

Zofran (ondansetron) has been under fire in past months with two studies suggesting a link between the drug and birth defects. In fact, the drugmaker, GlaxoSmithKline (GSK), is facing lawsuits stemming from claims that exposure to the drug Zofran during […]

Sheller, P.C.

Invokana Linked to Increased Risk of Diabetic Ketoacidosis in New Trial

The findings of a new clinical trial suggest Invokana (canagliflozin), used for treating Type 2 diabetes may also help to treat people with Type 1 diabetes by controlling blood sugar. But, it may increase the risk of diabetic ketoacidosis (DKA) […]

Sheller, P.C.

$15.5 Million Settlement in Risperdal Failure to Warn, Off-Label Marketing Lawsuit

A settlement of $15.5 million was reached between the Kentucky Attorney General and Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) regarding the drug Risperdal, used widely to treat schizophrenia. The suit was originally filed with allegations that the drug […]

Sheller, P.C.

Three of Four Pennsylvania Risperdal Lawsuits Favor Plaintiffs

Janssen Pharmaceuticals (a Johnson & Johnson subsidiary) is currently facing at least 1,600 Risperdal cases pending in Philadelphia court. A prescription medication used to treat bipolar disorder and schizophrenia, Risperdal is at the center of numerous lawsuits on behalf of male […]

Sheller, P.C.

Is a Xarelto Bleeding Antidote in Sight?

Portola Pharmaceuticals has designed a treatment to reverse the effects of blood thinners Xarelto and Eliquis. The anti-anticoagulant came through in a pair of Phase III trials and is poised for final FDA submission. The treatment, andexanet alfa, works as […]